跳至主要内容
临床试验/ACTRN12617001347358
ACTRN12617001347358已完成1 期

The effect of 1,3-butanediol on immunity, tolerability and performance in well-trained, healthy male cyclists.

Auckland University of Technology0 个研究点目标入组 9 人开始时间: 2017年9月25日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 35 Years(—)
性别
Male

入选标准

  • Endurance-trained male cyclists; VO2peak >60mlkg/min; 18 – 35 years; history of competition; training for >2 years; train >6 hours per week; habitually consuming a mixed diet for at least 1 year; weight stable for >1 month.

排除标准

  • Possess cardiovascular, metabolic, neurological, immunological or autoimmune disorders; baseline haematological values (leukocytes and erythrocyte counts) outside of normal range; experienced illness and/or upper respiratory symptoms within the previous 4 weeks; experienced GI symptoms within the previous 4 weeks or has a history of GI symptomology; consumed medications or supplements known to effect immunity within previous 2 weeks; smoker or previously smoked; family member has died before the age of 50 due to a heart condition.

研究者

相似试验